Long-standing pili torti in 2 patients with chronic graft-vs-host disease
نویسندگان
چکیده
cGVHD: chronic graft-vs-host disease HSCT: hematopoietic stem cell transplant INTRODUCTION Pili torti is a term that originates from Latin (pili meaning hair, torti meaning twisted) used to describe the irregularly flattened and twisted appearance of hair shafts on microscopic hair mount evaluation. Clinically, affected patients have fragile, coarse, and sparse hair. The 1808 rotation along the hair shaft axis is thought to be caused by perifollicular fibrosis and abnormalities of the inner root sheath, with subsequent irregular formation of the hair shaft. The characteristic narrow and numerous twists distinguish pili torti from other types of hair shaft disorders. Congenital pili torti has been associated with a number of syndromes, including Bj€ ornstad syndrome, Menkes syndrome, and others. Bj€ ornstad syndrome is known to be caused by a missense mutation in the BCS1L gene on chromosome 2q34-36. BCS1L encodes an ATPase that has a central role in the proper functioning of the electron transport chain. In Bj€ ornstad syndrome, BSC1L mutations cause variable degrees of pili torti and sensorineural hearing loss, shown to be due to disrupted mitochondrial respirasome assembly and increased production of reactive oxygen species. Reports of acquired pili torti are few and have been associated with the use of oral retinoids and erlotinib and, in some patients, cicatricial alopecia. In these cases, however, the pili torti is localized, and medication-induced cases tend to resolve after discontinuation of the offending agent. Herein we describe 2 women with chronic graft-vs-host disease (cGVHD) with long-standing, diffuse alopecia and pili torti.
منابع مشابه
Treatment of chronic cutaneous graft versus host disease (GVHD) with photochemotherapy with Psoralen (PUVA): A report of five cases
Chronic graft versus host disease (GVHD) remains the most common late complication of allogenic stem cell transplantation and the most frequent cause of morbidity and mortality in these patients. To control this condition, immunosuppressive drugs are usually administered at a high dose and for a long time, which may result in several side effects. 5 patients with clinically and histopathologica...
متن کاملEvaluation of narrow band UVB therapeutic effect on chronic mucocutaneous graft versus host disease lesions: A case series
Background: Chronic graft versus host disease (cGVHD) is a major cutaneous complication of bone marrow transplantation (BMT). Although milder forms of this process may be associated with a lower incidence of tumor recurrences, it is mandatory to develop a more efficient and less harmful therapeutic approach.Methods: This case-series study enrolled 7 patients diagnosed with chronic mucocutaneous...
متن کاملLow Dose Psoralen Plus Ultraviolet A (PUVA) Is an Effective and Safe Method for the Treatment of Chronic Graft Versus Host Disease
Background: Chronic graft versus host disease (ch.GVHD) is the most frequent late complication after allogenic stem-cell transplantation. Systemic immunosuppressive agents are usually required to control the disease. Psoralen plus UVA (PUVA) has been used for the treatment of ch.GVHD with variable beneficial effects. The objective of this study was to assess the efficacy and safety of a r...
متن کاملEvaluation of narrow band UVB therapeutic effect on chronic mucocutaneous graft versus host disease lesions: A case series
Background: Chronic graft versus host disease (cGVHD) is a major cutaneous complication of bone marrow transplantation (BMT). Although milder forms of this process may be associated with a lower incidence of tumor recurrences, it is mandatory to develop a more efficient and less harmful therapeutic approach.Methods: This case-series study enrolled 7 patients diagnosed w...
متن کاملProlonged sirolimus administration after allogeneic hematopoietic cell transplantation is associated with decreased risk for moderate-severe chronic graft-versus-host disease.
Effective pharmacological strategies employed in allogeneic hematopoietic cell transplantation should prevent serious chronic graft-versus-host disease and facilitate donor-recipient immune tolerance. Based on demonstrated pro-tolerogenic activity, sirolimus (rapamycin) is an agent with promise to achieve these goals. In a long-term follow-up analysis of a randomized phase II trial comparing si...
متن کامل